Molekularne mechanizmy nowotworzenia Papillomaviridae u zwierzat i ludzi

• Autorzy: Szczerba-Turek A , Szweda W. , Siemionek J. , Platt-Samoraj A. , Bancerz-Kisiel A. , Teodorowski P.

Warianty tytułu

EN

Molecular mechanisms of carcinogenesis caused by Papillomaviridae in animals and humans

• Języki publikacji: PL

Abstrakty

EN

Papillomaviruses (PV) are small, nonenveloped, DNA viruses, which had originally been grouped together with the Polyomaviruses in one family, Papovaviridae. In the year 2004 the International Committee on the Taxonomy of Viruses officially recognized two separate families: Papillomaviridae and Polyomaviridae. PV are pathogens of skin and mucosa in animals and humans, and they are very species-specific. The only known case of cross-species infection is the infection of horses by bovine papillomaviruses (BPV) type 1 and 2. Infection by high-risk types of human papillomaviruses (HPV) such as HPV type 16 and 18 is directly related to the subsequent development of cervical carcinoma in women. In the year 1995 The International Agency for Research on Cancer officially declared, that HPV-16 and HPV-18 are carcinogenic for humans. Animal PV cause various diseases in both farm and companion animals, e.g. skin and teat papillomatosis in cattle, canine oral papillomatosis, oesophageal papillomas and carcinoma in cattle and equine sarcoids. The mechanisms of carcinogenesis caused by PV were initially established using animal models and specifically chosen PV, particularly cottontail rabbit papillomavirus (CRPV), BPV and canine oral papillomavirus (COPV). In the paper the organization and structure of the PV genome, the characteristics of early and late regions, enzymatic and regulatory proteins, encoded by specific open reading frames and engaged in virus replication process, as well as structural proteins that take part in virus-cell interaction have been discussed. The replication process of PV and mechanisms of carcinogenic transformation of cells infected with PV were also described. The possibility of the implementation of specific immunoprophylaxis and the necessity of improvement of diagnostic methods, as well as conducting molecular comparative studies of human and animal PV, important for the protection of animal health and public health, have been indicated.

Słowa kluczowe

PL

papillomawirusy; Papillomaviridae; mechanizmy molekularne; onkogeneza

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2007
• Tom: 63
• Numer: 09
• Opis fizyczny: s.1045-1048,bibliogr.

Twórcy

autor

Szczerba-Turek A

• Uniwersytet Warminsko-Mazurski w Olsztynie, ul.Oczapowskiego 13, 10-719 Olsztyn

autor

Szweda W.

autor

Siemionek J.

autor

Platt-Samoraj A.

autor

Bancerz-Kisiel A.

autor

Teodorowski P.

Bibliografia

• 1.Anon.: IARC/WHO Papillomaviruses. IARC monographs on the evaluation of carcinogenic risks to humans. World Health Organization International Agency for Research on Cancer 1995, 64, 261-274.
• 2.Bernard B. A., Bailly C., Lenoir M. C., Darmon M., Thierry F., Yaniv M.: The human papillomavirus type 18 E2 gene product is a repressor of the HPV 18 regulatory region in human keratinocytes. J. Virol. 1989, 63, 4317-4324.
• 3.Borzacchiello G., Ambrosio V., Roperto S., Poggiali F., Tsirimonakis E., Venuti A., Campo M. S., Roperto F.: Bovine papillomavirus type 4 in oesophageal papillomas of cattle from the South of Italy. J. comp. Path. 2003, 128, 203-206.
• 4.Brandsma J. L.: Animal models of human papillomavirus-associated oncogenesis. Intervirology 1994, 37, 189-200.
• 5.Campo M. S.: Animal models of papillomavirus pathogenesis. Virus Res. 2002, 89, 249-261.
• 6.Chambers G., Ellsmore V. A., O’Brien P. M., Reid S. W. J., Love S., Campo M. S., Nasir L.: Association of bovine papillomavirus with equine sarcoid. J. Gen. Virol. 2003, 84, 1055-1062.
• 7.Cromme F. V., Walboomers J. M. M., Van Oostveen J. W., Stukart M. J., De Gruijl T. D., Kummer J. A., Leonhart A. M., Helmerhorst T. J. M., Meijer C. J. L. M.: Lack of granzyme expression in T lymphocytes indicates poor cytotoxic T lymphocyte activation in human papillomavirus-associated cervical carcinomas. Int. J. Gynecol. Cancer 1995, 5, 366-373.
• 8 Damasus-Awantai G., Freeman-Wang T.: Human papilloma virus and cervical screening. Curr. Opin. Obstet. Gynecol. 2003, 15, 473-477.
• 9.Dyson N., Howley P. M., Munger K., Harlow E.: The human papillomavirus 16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989, 243, 934-937.
• 10.Evender M., Frazer I. H., Payne E.: Identification of the alpha 6 integrin as a candidate receptor for papillomavirus. J. Virol. 1997, 71, 2449-2456.
• 11.Fehrmann F., Laimins L. A.: Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene 2003, 22, 5201- -5207.
• 12.Ham J. N., Dostatni J. M. G., Yanin M.: The papillomavirus E2 protein: a factor with many talents. Trends Biochem. Sci. 1991, 16, 440-444.
• 13.Jackson M. E., Pennie W. D., Mc Caffery R. E., Smith K. T., Grindlay G. J., Campo M. S.: The B subgroup of bovine Papillomaviruses lack an identifiable E6 open reading frame. Mol. Carcinogenesis 1991, 4, 382-387.
• 14.Johnson D. G., Schwarz J. K., Cress W. D., Nevins J. R.: Expression of transcription factor E2F induces quiescent cells to enter S phase. Nature 1993, 365, 349-352.
• 15.Kwaśniewska A.: Infekcje wirusem brodawczaka ludzkiego (HPV-Human Papillomavirus), surowiczy poziom antyoksydantów oraz rola żywienia w dysplazji szyjki macicy. Praca hab., Akademia Medyczna, Lublin 1998.
• 16.Lam E. W. F., Morris J. D. H., Davies R., Crook T., Watson R. J., Vousden K. H.: HPV 16 E7 oncoprotein deregulates b-myc expression: correlation with targeting of p107/E2F complexes. EMBO J. 1994, 13, 87-88.
• 17.Lechner M. S., Mack D. H., Finicle A. B., Crook T., Vousden K. H., Laimins L. A.: Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J. 1992, 11, 3045- -3052.
• 18.Matsukura T., Koi S., Sugase M.: Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology 1989, 172, 63-72.
• 19.Ogawa T., Tomita Y., Okada M., Shinozaki K., Kubonoya H., Kaiho I., Shirasawa H.: Broad-spectrum detection of papillomaviruses in bovine teat papillomas and healthy teat skin. J. Gen. Virol. 2004, 85, 2191-2197.
• 20.Sapierzyñski R., Sapierzyñska E.: Nowotwory nabłonkowe skóry u psów i kotów. Część I. Nowotwory wywodzące się z nabłonków pokrywających. Życie Wet. 2005, 80, 94-99.
• 21.Scheffner M., Huibregste J. M., Vierstra R. D., Howley P. M.: The HPV 16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993, 75, 495-505.
• 22.Slebos R. J. C., Lee M. H., Plunkett B. S., Kessis T. D., Williams B. O., Jacks T.: p53-dependent G(1) arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natn. Acad. Sci. USA 1994, 91, 5320-5324.
• 23.Standbridge E. J.: Identifying tumor suppressor genes in human colorectal cancer. Science 1990, 247, 12-13.
• 24.Tachezy R., Rector A., Havelkova M., Wollants E., Fiten P., Opdenakker G., Jenson A. B., Soudberg J. P., Van Rast M.: Avian papillomavirus: the parrot Psittacus erithacus papillomavirus (PePv) genome has a unique organization of the early protein region and is phylogenetically related to the chaffinch papillomavirus. BMC Microbiology 2002, 2, 19.
• 25.Ustav M., Ustav E., Szymañski P., Stenlund A.: Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1. EMBO J. 1991, 10, 4321-4329.
• 26.Villiers E.-M. de, Fauquet C., Broker T. R., Bernard H. U., zur Hausen H.: Classification of papillomaviruses. Virology 2004, 324, 17-27.
• 27.Werness B. A., Levine A. J., Howley P. M.: Associations of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990, 248, 76-79.
• 28.White A. E., Livanos E. M., Tlsty T. D.: Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev. 1994, 8, 666-677.
• 29.Wiśniewski E., Janiszewski J.: Nowotwory skóry u koni. Medycyna Wet. 1994, 50, 212-215.
• 30.Wright T. C., Bosch F. X., Franco E. L., Cuzick J., Schiller J. T., Garnett G. P., Meheus A.: Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts. Vaccine 2006, 24S3, 251-261.